Ganhua You, 1, 2 Xiangshu Long, 3, 4 Fang Song, 3, 4 Jing Huang, 3, 4 Maobo Tian, 3, 4 Yan Xiao, 3, 4 Shiyan Deng, 3, 4 Qiang Wu 3, 4
1Guizhou University School of Medicine, Guiyang 550025, Peoples Republic of China; 2Guizhou Institute for Food and Drug Control, Guiyang 550004, Peoples Republic of China; 3Department of Cardiology, Guizhou Provincial Peoples Hospital, Guiyang 550002, Peoples Republic of China; 4Department of Cardiology, Peoples Hospital of Guizhou University, Guiyang 550002, Peoples Republic of China
Correspondence: Qiang WuDepartment of Cardiology, Guizhou Provincial Peoples Hospital, 83 Zhongshan East Road, Guiyang, Guizhou, Peoples Republic of ChinaTel +86-0851-85937194Fax +86-0851-85924943Email wqgz0851@126.com
Background: Metformin has been shown to inhibit the proliferation and migration of vascular wall cells. However, the mechanism through which metformin acts on atherosclerosis (AS) via the long non-coding RNA taurine up-regulated gene 1 (lncRNA TUG1) is still unknown. Thus, this research investigated the effect of metformin and lncRNA TUG1 on AS.Methods: First, qRT-PCR was used to detect the expression of lncRNA TUG1 in patients with coronary heart disease (CHD). Then, the correlation between metformin and TUG1 expression in vitro and their effects on proliferation, migration, and autophagy in vascular wall cells were examined. Furthermore, in vivo experiments were performed to verify the anti-AS effect of metformin and TUG1 to provide a new strategy for the prevention and treatment of AS.Results: qRT-PCR results suggested that lncRNA TUG1 expression was robustly upregulated in patients with CHD. In vitro experiments indicated that after metformin administration, the expression of lncRNA TUG1 decreased in a time-dependent manner. Metformin and TUG1 knockdown via small interfering RNA both inhibited proliferation and migration while promoted autophagy via the AMPK/mTOR pathway in vascular wall cells. In vivo experiments with a rat AS model further demonstrated that metformin and sh-TUG1 could inhibit the progression of AS.Conclusion: Taken together, our data demonstrate that metformin might function to prevent AS by activating the AMPK/mTOR pathway via lncRNA TUG1.
Keywords: metformin, taurine up-regulated gene 1, AMPK/mTOR, autophagy, atherosclerosis
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
View original post here:
Metformin Activates the AMPK-mTOR Pathway by Modulating lncRNA TUG1 to | DDDT - Dove Medical Press
Recommendation and review posted by G. Smith
